Podcast: Drug Company’s Subsidies to Patients Under Review

Annie Baxter of Marketplace discusses the newly-announced federal investigation of Valeant Pharmaceuticals’ patient subsidy program, which critics allege is merely marketing ploy that costs patients more money in the long term.

 

+ posts

Share

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email

Subscribe to get the latest consumer news

More consumer News